Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast Cancer
Clinical trial NCT00810017 · TERMINATED
Trial details
- NCT number
- NCT00810017
- Sponsor
- Medstar Health Research Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2010-05-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.